Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Evolution of Minimally Invasive Mitral Valve Repair: 30-Year Experience From a High-Volume Center.

Annals of thoracic surgery short reports·2025
Same author

Transcatheter valve repair of tricuspid regurgitation: 1-year outcomes from the TriCLASP study.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2025
Same author

Epicardial and endocardial surgical ablation of atrial fibrillation: outcomes from CASE-AF Registry.

Interdisciplinary cardiovascular and thoracic surgery·2024
Same author

γ-Glutamyl Transferase and Long-Term Survival in the SYNTAXES Trial: Is It Just the Liver?

Journal of the American Heart Association·2024
Same author

Prevalence of Genetic Variants and Deep Phenotyping in Patients with Thoracic Aortic Aneurysm and Dissection: A Cross-Sectional Single-Centre Cohort Study.

Journal of clinical medicine·2024
Same author

Reduction of volume loss after left atrial injury by balloon occlusion-an experimental study.

Journal of thoracic disease·2023

Video Experimental Relacionado

Updated: May 12, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

Resultados a medio plazo después del reemplazo de la válvula mitral sin stent.

Thomas Walther1, Sven Lehmann, Volkmar Falk

  • 1Klinik für Herzchirurgie, Universität Leipzig, Herzzentrum, Leipzig, Germany. walt@medizin.uni-leipzig.de

Circulation
|September 13, 2003
PubMed
Resumen

Los resultados a medio plazo para el reemplazo de la válvula mitral sin stent son prometedores, mostrando una función ventricular izquierda estable y una mejor hemodinámica. La durabilidad a largo plazo de la válvula mitral sin stent necesita más investigación.

Más Videos Relacionados

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

Videos de Experimentos Relacionados

Last Updated: May 12, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

Área de la Ciencia:

  • Cirugía cardiovascular La cirugía cardiovascular es una cirugía cardiovascular.
  • Reparación y reemplazo de válvulas cardíacas.

Sus antecedentes:

  • La enfermedad grave de la válvula mitral requiere intervención quirúrgica.
  • El reemplazo de la válvula mitral sin stent (SMV) ofrece una solución potencial para patologías complejas de la válvula.

Objetivo del estudio:

  • Para evaluar los resultados clínicos a medio plazo de los pacientes sometidos a reemplazo de válvula mitral (VMS) sin stent.
  • Para evaluar el estado funcional y el rendimiento hemodinámico después de la implantación de SMV.

Principales métodos:

  • Cincuenta y un pacientes con enfermedad severa de la válvula mitral se sometieron a implantación de SMV con apoyo cordial.
  • Los procedimientos se realizaron a través de enfoques convencionales o mínimamente invasivos.
  • El seguimiento incluyó ecocardiografía y evaluación clínica durante un promedio de 35.4 meses.

Principales resultados:

  • La implantación exitosa de SMV se logró en 51 pacientes con enfermedad severa de la válvula mitral.
  • Se requirieron reoperaciones tempranas en cinco pacientes por complicaciones como fuga paravalvular y estenosis.
  • La ecocardiografía a medio plazo demostró una buena función de la VMS y una fracción de eyección ventricular izquierda preservada.

Conclusiones:

  • La implantación de válvula mitral sin stent muestra resultados clínicos a medio plazo prometedores.
  • La preservación de la continuidad annuloventricular contribuye a una función ventricular izquierda estable.
  • La durabilidad a largo plazo de la válvula mitral sin stent requiere más estudios a largo plazo.